- Buvanendran A, Kroin J S, Tuman K J, Lubenow T R, Elmofty D, Moric M, Rosenberg A. Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: a randomized controlled trial. JAMA 2003; 290(18)2411–8
- Caldwell B S, Aldington S, Weatherall M, Shirtciffe P, Beasley R. Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis. J R Soc Med 2006; 99(3)132–40
- Cushner F D, Friedman R J. Blood loss in total knee arthroplasty. Clin Orthop 1991; 269: 98–101
- Eisen G M, Goldstein J L, Hanna D B, Rublee D A. Metaanalysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase-2-specific inhibitor, compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis. Aliment Pharmacol Ther 2005; 21(5)591–8
- Fauno P, Petersen K D, Husted S E. Increased blood loss after preoperative NSAID. Retrospective study of 186 hip arthroplasties. Acta Orthop Scand 1993; 64(5)522–4
- Flordal P A, Neander G. Blood loss in total hip replacement. A retrospective study. Arch Orthop Trauma Surg 1991; 111(1)34–8
- Good L, Peterson E, Lisander B. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br J Anaesth 2003; 90(5)596–9
- Leese P T, Hubbard R C, Karim A, Isakson P C, Yu S S, Geis G S. Effects of celecoxib, a novel cyclooxygenase- 2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial. J Clin Pharmacol 2000; 40(2)124–32
- Lisander B, Jacobsson S A, Ivarsson I, Vegfors M, Engdahl O. Giving both enoxaparin and dextran increases the need for transfusion in revision hip arthroplasty. Eur J Surg 1996; 162(11)861–6
- Mercuriali F, Inghilleri G. Proposal of an algorithm to help the choice of the best transfusion strategy. Curr Med Res Opin 1996; 13(8)465–78
- Moore R A, Derry S, Makinson G T, McQuay H J. Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports. Arthritis Res Ther 2005; 7(3)644–65
- Nadler S B, Hidalgo J U, Bloch T. Prediction of blood volume in normal human adults. Surgery 1962; 51: 224–32
- Pincus T, Koch G, Lei H, Mangal B, Sokka T, Moskowitz R, Wolfe F, Gibofsky A, Simon L, Zlotnick S, Fort J G. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. Ann Rheum Dis 2004; 63(8)931–9
- Reuben S S, Fingeroth R, Krushell R, Maciolek H. Evaluation of the safety and efficacy of the perioperative administration of rofecoxib for total knee arthroplasty. J Arthroplasty 2002; 17(1)26–31
- Roos E M, Roos H P, Ekdahl C, Lohmander L S. Knee injury and Osteoarthritis Outcome Score (KOOS)-validation of a Swedish version. Scand J Med Sci Sports 1998; 8(6)439–48
- Roos E M, Toksvig-Larsen S. Knee injury and Osteoarthritis Outcome Score (KOOS) – validation and comparison to the WOMAC in total knee replacement. Health Qual Life Outcomes 2003; 1(1)17
- Schnitzer T J, Weaver A L, Polis A B, Petruschke R A, Geba G P. Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies. J Rheumatol 2005; 32(6)1093–105
- Sehat K R, Evans R, Newman J H. How much blood is really lost in total knee arthroplasty? Correct blood loss management should take hidden loss into account. Knee 2000; 7(3)151–5
- Sehat K R, Evans R, Newman J H. Hidden blood loss following hip and knee arthroplasty. Correct management of blood loss should take hidden loss into account. J Bone Joint Surg (Br) 2004; 86(4)561–5
- Slappendel R, Weber E W, Benraad B, Dirksen R, Bugter M L. Does ibuprofen increase perioperative blood loss during hip arthroplasty?. Eur J Anaesthesiol 2002; 19(11)829–31
- Weber E W, Slappendel R, Durieux M E, Dirksen R, van der Heide H, Spruit M. COX 2 selectivity of non-steroidal anti-inflammatory drugs and perioperative blood loss in hip surgery. A randomized comparison of indomethacin and meloxicam. Eur J Anaesthesiol 2003; 20(12)963–6
- White W B, Faich G, Borer J S, Makuch R W. Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase- 2 inhibitor celecoxib. Am J Cardiol 2003; 92(4)411–8
Acta Orthopaedica
Volume 78, 2007 - Issue 5